Effect of empagliflozin on cardiovascular events including recurrent events in the EMPA-REG OUTCOME trial
28 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
University of Texas Southwestern Medical Center, Dallas (United States of America)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
08:30 CET
You may be interested in
Congress Presentation
3 September 2019
Congress Session
29 August 2025
Congress Session
Webinar
